Edible Vaccines Industry Outlook to 2028 & 2033: Worldwide Revenues Set to Reach $12.5 Billion by 2028
December 11, 2024 07:06 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Edible Vaccine Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The edible vaccine market size has grown strongly in...
Global Cholera Vaccines Market - Global Inactivated Vaccine, Live Attenuated Vaccine, Injectable Vaccines, Oral Vaccines Forecast 2024-2030
August 30, 2024 04:05 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines),...
Global Cholera Vaccines Market 2023-2028: Key Players Like Merck, Johnson & Johnson and Sanofi are Leading the Way in Research and Investment
September 29, 2023 05:38 ET
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global Cholera Vaccines Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
May 16, 2022 08:33 ET
|
Research and Markets
Dublin, May 16, 2022 (GLOBE NEWSWIRE) -- The "Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Emergent BioSolutions Announces FDA Approval of Change in Storage Conditions and Transfer of Manufacturing for Its Cholera Vaccine
June 04, 2019 16:05 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., June 04, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced approval by the U.S. Food and Drug Administration (FDA) of the Prior Approval Supplement...